SCHEMBL985923

SCHEMBL985923

C=Cc1ccccc1C([O])=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
CYP3A4 P08684 2/20 0.39
ALOX15 P16050 1/20 0.39
BCHE P06276 1/20 0.37
GUSB P08236 1/20 0.37
AKT1 P31749 1/20 0.37
GSR P00390 1/20 0.36
LMNA P02545 2/20 0.35
MEN1 O00255 1/20 0.35
THRB P10828 1/20 0.35
BLM P54132 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TSHR P16473 3/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 1/20 0.34
CYP1A2 P05177 1/20 0.34
CES2 O00748 2/20 0.33
CES1 P23141 2/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL28793487 0.84 ALDH1A1 (0.54) ALDH1A1ALOX15AKT1LMNAMEN1
SCHEMBL6693580 0.84 CES2 (0.44) ALDH1A1CYP3A4ALOX15BCHEGUSB
SCHEMBL38132 0.84 ALDH1A1 (0.44) ALDH1A1CYP3A4ALOX15BCHEGUSB
SCHEMBL5369812 0.83 ALDH1A1 (0.47) ALDH1A1CYP3A4ALOX15BCHEGUSB
Benzene SCHEMBL28254104 0.82 ALDH1A1 (0.56) ALDH1A1ALOX15AKT1LMNATDP1
SCHEMBL30259301 0.82 ALDH1A1 (0.56) ALDH1A1ALOX15AKT1LMNATDP1
SCHEMBL31100 0.82 ALDH1A1 (0.56) ALDH1A1ALOX15AKT1LMNATDP1
Bicarbonate SCHEMBL15861641 0.80 ALDH1A1 (0.50) ALDH1A1ALOX15AKT1GSRLMNA
SCHEMBL2536413 0.80 AKT1 (0.50) ALDH1A1CYP3A4ALOX15BCHEGUSB
SCHEMBL2856375 0.80 ALDH1A1 (0.54) ALDH1A1ALOX15AKT1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0747734-B1 Contact lenses with hydrophilic crosslinkers JOHNSON & JOHNSON VISION PROD (US) 2001-08-22 EP claimed
US-5654350-A POLYMERIZATION OF MONOMER MIXTURE CONTAINING A CARBOXYL FUNCTIONAL CURING AGENT HAVING UNSATURATED END GROUPS AND ESTER AND/OR ETHER GROUPS JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) 1997-08-05 US claimed
EP-0747734-A2 Contact lenses with hydrophilic crosslinkers JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) 1996-12-11 EP claimed
US-5565539-A UNSATURATED ESTER CROSSLINKING AGENT; IMPROVED OXYGEN TRANSMISSIVITY JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) 1996-10-15 US claimed
US-5563183-A DIFFUSION OF WATER AND OXYGEN JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) 1996-10-08 US claimed
JP-9143230-A None JP disclosed
WO-2024070641-A1 OPTICAL FILM, POLARIZING PLATE, COMPOSITION FOR ALIGNMENT FILM FORMATION, AND METHOD FOR PRODUCING POLARIZING PLATE 富士フイルム株式会社 2024-04-04 WO disclosed
WO-2024070633-A1 OPTICAL FILM, POLARIZING PLATE, COMPOSITION FOR FORMING ALIGNMENT FILM, AND METHOD FOR PRODUCING POLARIZING PLATE 富士フイルム株式会社 2024-04-04 WO disclosed
US-8025936-B2 Optical compensation film, polarizing plate and liquid crystal display device FUJIFILM CORPORATION (JP) 2011-09-27 US disclosed
US-7875325-B2 comprising a transparent film, and, on the film, at least one layer formed by applying a composition comprising a zirconium compound, a vinyl alcohol-based resin, and an aminocarboxylic acid or its derivative to a surface FUJIFILM CORPORATION (JP) 2011-01-25 US disclosed
US-20090091690-A1 Optical Compensation Film, Polarizing Plate and Liquid Crystal Display Device FUJIFILM CORPORATION (JP) 2009-04-09 US disclosed
US-20090086130-A1 OPTICAL FILM, POLARIZING PLATE, AND LIQUID-CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
JP-H09143230-A CONTACT LENS CONTAINING HYDROPHILIC CROSS-LINKING AGENT AND ITS PRODUCTION JOHNSON & JOHNSON VISION PROD INC 1997-06-03 JP disclosed
EP-0747734-A2 Contact lenses with hydrophilic crosslinkers JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) 1996-12-11 EP disclosed
US-5565539-A UNSATURATED ESTER CROSSLINKING AGENT; IMPROVED OXYGEN TRANSMISSIVITY JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) 1996-10-15 US disclosed
US-5565539-A UNSATURATED ESTER CROSSLINKING AGENT; IMPROVED OXYGEN TRANSMISSIVITY JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) 1996-10-15 US disclosed
US-5563183-A DIFFUSION OF WATER AND OXYGEN JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) 1996-10-08 US disclosed
US-5563183-A DIFFUSION OF WATER AND OXYGEN JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) 1996-10-08 US disclosed
EP-0726486-A2 Optical compensatory sheet FUJI PHOTO FILM CO., LTD. (JP) 1996-08-14 EP disclosed
US-4855282-A Recording material and method for producing the same FUJI PHOTO FILM CO., LTD. (JP) 1989-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090086130-A1 OPTICAL FILM, POLARIZING PLATE, AND LIQUID-CRYSTAL DISPLAY DEVICE ZKSCAN2, VCL, ZRANB2 ALDH1A1 2609/4885CYP3A4 2806/4885ALOX15 1076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.